NexGel Inc (NXGL)
2.32
+0.12
(+5.45%)
USD |
NASDAQ |
May 07, 16:00
2.32
0.00 (0.00%)
After-Hours: 20:00
NexGel SG&A Expense (Quarterly): 1.22M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.22M |
September 30, 2023 | 0.893M |
June 30, 2023 | 0.803M |
March 31, 2023 | 0.743M |
December 31, 2022 | 0.702M |
September 30, 2022 | 0.724M |
June 30, 2022 | 0.653M |
March 31, 2022 | 0.71M |
December 31, 2021 | 0.844M |
September 30, 2021 | 0.55M |
June 30, 2021 | 0.543M |
March 31, 2021 | 0.444M |
Date | Value |
---|---|
December 31, 2020 | 0.525M |
September 30, 2020 | 0.508M |
June 30, 2020 | 0.455M |
March 31, 2020 | 0.576M |
December 31, 2019 | 0.276M |
September 30, 2019 | 0.00 |
June 30, 2019 | 1.007M |
March 31, 2019 | 0.504M |
December 31, 2018 | 0.749M |
September 30, 2018 | 0.744M |
June 30, 2018 | 0.572M |
December 31, 2017 | 0.341M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2019
1.22M
Maximum
Dec 2023
0.6408M
Average
0.653M
Median
Jun 2022
SG&A Expense (Quarterly) Benchmarks
Anika Therapeutics Inc | 20.34M |
The Cooper Companies Inc | 380.90M |
Staar Surgical Co | 39.45M |
OrthoPediatrics Corp | 32.03M |
Innovative Eyewear Inc | 2.160M |